FDA to Prioritize Processing of ACE Entries
The Food and Drug Administration is "providing priority processing for ACE entries of FDA-regulated products," CBP said in a CSMS message (here). "The data shows average processing time for manual review and release of ACE submitted entries is 25% faster…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
than for [Automated Commercial System] submitted entries, and release times for document reviews is 33% faster than for ACS submitted entries (a time savings of 1 ½ days)," it said. "We expect review times to improve as entry filers make the transition to ACE; FDA will be updating the data and charts on a weekly basis." Starting June 15, use of ACE will be mandatory for electronic FDA cargo release and entry summary submissions, a major milestone in the ACE transition (see 1606100012). The FDA also created a new page on its website dedicated to the ACE transition (here). The FDA will also use "production calls" to give guidance to importers and entry filers on ACE and will "allow FDA and CBP to collaborate on entries requiring attention from both agencies," CBP said.